1 Beaten-Down Stock to Buy and Hold for 10 Years

Viking Therapeutics (VKTX 3.44%) was one of the hottest biotech stocks of 2024; its shares soared last year following excellent clinical progress. However, things have been very different in 2025, at least so far: Its stock is down by 35% year to date due to a combination of factors.Should you steer clear of Viking Therapeutics? My view is that despite its struggles this year, there's still significant upside. Let's find out why it could be a top stock to hold for the long term.Why Viking Therapeutics' shar ...